About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(KLK3-cre)D4Trp
transgene insertion D4, Jan Trapman
MGI:3761848
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Ptentm1Mro/Pten+
Tg(KLK3-cre)D4Trp/0
involves: 129P2/OlaHsd * FVB MGI:3761927
cn2
Ptentm1Mro/Ptentm1Mro
Tg(KLK3-cre)D4Trp/0
involves: 129P2/OlaHsd * FVB MGI:3761928
cn3
Ptentm1Mro/Ptentm1Mro
Sdhbtm1.1Ics/Sdhbtm1.2Ics
Tg(KLK3-cre)D4Trp/0
involves: 129S2/SvPas * BALB/c * C57BL/6 * FVB MGI:5812678
cn4
Sdhbtm1.1Ics/Sdhbtm1.1Ics
Tg(KLK3-cre)D4Trp/0
involves: 129S2/SvPas * FVB MGI:5812673
cn5
Ptentm1Mro/Ptentm1Mro
Sdhbtm1.1Ics/Sdhb+
Tg(KLK3-cre)D4Trp/0
involves: 129S2/SvPas * FVB MGI:5812676
cn6
Ptentm1Mro/Pten+
Sdhbtm1.1Ics/Sdhb+
Tg(KLK3-cre)D4Trp/0
involves: 129S2/SvPas * FVB MGI:5812679


Genotype
MGI:3761927
cn1
Allelic
Composition
Ptentm1Mro/Pten+
Tg(KLK3-cre)D4Trp/0
Genetic
Background
involves: 129P2/OlaHsd * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptentm1Mro mutation (1 available); any Pten mutation (88 available)
Tg(KLK3-cre)D4Trp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• at 4-5 months, epithelial cell lining of prostate tubules is disorganized, with tufting and/or cribriform growth patterns, unlike the regularly-layered columnar epithelial lining in controls
• epithelial cells are generally enlarged with some foci showing dysplasia characterized by cells with dense cytoplasm enlarged, somewhat vesicular nuclei with conspicuous nuclei
• at 7-9 months, distention of glands continues, with dysplasia becoming more diffuse
• prostate lobes are obviously enlarged compared with control prostates; at 4-5 months, average weight is increased 2-fold and at 7-9 months increase is 3-fold
• at 14 months with prostate cancer, weight has rapidly increased
• at 4-5 months of age, most glands of the different lobes show hyperplasia with accumulation of luminal cells, with distension of individual preexisting glands
• at 7-9 months hyperplasia continues to progress
• progressive tumor development is observed in mice at 4-5 months along with focal prostatic intraepithelial neoplasia (PIN) lesions, 7-9 months with more widespread PIN and focal microinvasion and at 10-14 months with invasive tumors
• in 14-month old mice, tumors are all shown to be epithelial in origin, classified as adenocarcinoma of poor, low or moderate grade differentiation

endocrine/exocrine glands
• at 4-5 months, epithelial cell lining of prostate tubules is disorganized, with tufting and/or cribriform growth patterns, unlike the regularly-layered columnar epithelial lining in controls
• epithelial cells are generally enlarged with some foci showing dysplasia characterized by cells with dense cytoplasm enlarged, somewhat vesicular nuclei with conspicuous nuclei
• at 7-9 months, distention of glands continues, with dysplasia becoming more diffuse
• prostate lobes are obviously enlarged compared with control prostates; at 4-5 months, average weight is increased 2-fold and at 7-9 months increase is 3-fold
• at 14 months with prostate cancer, weight has rapidly increased
• at 4-5 months of age, most glands of the different lobes show hyperplasia with accumulation of luminal cells, with distension of individual preexisting glands
• at 7-9 months hyperplasia continues to progress
• progressive tumor development is observed in mice at 4-5 months along with focal prostatic intraepithelial neoplasia (PIN) lesions, 7-9 months with more widespread PIN and focal microinvasion and at 10-14 months with invasive tumors
• in 14-month old mice, tumors are all shown to be epithelial in origin, classified as adenocarcinoma of poor, low or moderate grade differentiation

neoplasm
• progressive tumor development is observed in mice at 4-5 months along with focal prostatic intraepithelial neoplasia (PIN) lesions, 7-9 months with more widespread PIN and focal microinvasion and at 10-14 months with invasive tumors
• in 14-month old mice, tumors are all shown to be epithelial in origin, classified as adenocarcinoma of poor, low or moderate grade differentiation




Genotype
MGI:3761928
cn2
Allelic
Composition
Ptentm1Mro/Ptentm1Mro
Tg(KLK3-cre)D4Trp/0
Genetic
Background
involves: 129P2/OlaHsd * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptentm1Mro mutation (1 available); any Pten mutation (88 available)
Tg(KLK3-cre)D4Trp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• mutants show a 2-fold higher number of proliferating (BrdU-positive) cells at 4-5, 7-9, and 10-14 months

endocrine/exocrine glands
• mutants show a 2-fold higher number of proliferating (BrdU-positive) cells at 4-5, 7-9, and 10-14 months




Genotype
MGI:5812678
cn3
Allelic
Composition
Ptentm1Mro/Ptentm1Mro
Sdhbtm1.1Ics/Sdhbtm1.2Ics
Tg(KLK3-cre)D4Trp/0
Genetic
Background
involves: 129S2/SvPas * BALB/c * C57BL/6 * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptentm1Mro mutation (1 available); any Pten mutation (88 available)
Sdhbtm1.1Ics mutation (0 available); any Sdhb mutation (29 available)
Sdhbtm1.2Ics mutation (0 available); any Sdhb mutation (29 available)
Tg(KLK3-cre)D4Trp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• 42% incidence of pheochromocytoma
• tumors do not show accumulation of succinate

neoplasm
• 42% incidence of pheochromocytoma
• tumors do not show accumulation of succinate




Genotype
MGI:5812673
cn4
Allelic
Composition
Sdhbtm1.1Ics/Sdhbtm1.1Ics
Tg(KLK3-cre)D4Trp/0
Genetic
Background
involves: 129S2/SvPas * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sdhbtm1.1Ics mutation (0 available); any Sdhb mutation (29 available)
Tg(KLK3-cre)D4Trp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are viable, fertile and have no apparent phenotype




Genotype
MGI:5812676
cn5
Allelic
Composition
Ptentm1Mro/Ptentm1Mro
Sdhbtm1.1Ics/Sdhb+
Tg(KLK3-cre)D4Trp/0
Genetic
Background
involves: 129S2/SvPas * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptentm1Mro mutation (1 available); any Pten mutation (88 available)
Sdhbtm1.1Ics mutation (0 available); any Sdhb mutation (29 available)
Tg(KLK3-cre)D4Trp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• 89% of mice show pheochromocytoma at 12.9 months of age
• tumors do not show accumulation of succinate

neoplasm
• 89% of mice show pheochromocytoma at 12.9 months of age
• tumors do not show accumulation of succinate

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
pheochromocytoma DOID:0050771 OMIM:171300
J:236514




Genotype
MGI:5812679
cn6
Allelic
Composition
Ptentm1Mro/Pten+
Sdhbtm1.1Ics/Sdhb+
Tg(KLK3-cre)D4Trp/0
Genetic
Background
involves: 129S2/SvPas * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptentm1Mro mutation (1 available); any Pten mutation (88 available)
Sdhbtm1.1Ics mutation (0 available); any Sdhb mutation (29 available)
Tg(KLK3-cre)D4Trp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• 64% of mice develop pheochromocytoma

neoplasm
• 64% of mice develop pheochromocytoma





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory